Genetic predisposition to thrombosis in renal transplant recipients: The factor V Q506 (Leiden) Allele

Transplantation

Volumn 69, Issue 8, 2000, Pages 1547-1548

  Green, F R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 5 R506Q; PLASMINOGEN ACTIVATOR INHIBITOR 1; UNCLASSIFIED DRUG;

DISEASE PREDISPOSITION; GENE MUTATION; GENETIC RISK; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; KIDNEY GRAFT; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RACE DIFFERENCE; RISK FACTOR; THROMBOSIS;

EID: 0034720075     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200004270-00004     Document Type: Note

References (5)

1. Environmental and genetic determinants of the hypercoagulable state and cardiovascular disease in renal transplant recipients
2. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene
3. The factor V Leiden (R506Q) mutation and risk of thrombosis in renal transplant recipients
4. Early loss of renal transplants in patients with thrombophilia
5. High rate of acute rejections in renal allograft recipients with thrombophilic risk factors